Amarin Corporation PLC
NASDAQ:AMRN

Watchlist Manager
Amarin Corporation PLC Logo
Amarin Corporation PLC
NASDAQ:AMRN
Watchlist
Price: 16.46 USD 1.04%
Market Cap: 342.2m USD

Amarin Corporation PLC
Depreciation & Amortization

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Amarin Corporation PLC
Depreciation & Amortization Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
Amarin Corporation PLC
NASDAQ:AMRN
Depreciation & Amortization
$3.1m
CAGR 3-Years
-1%
CAGR 5-Years
11%
CAGR 10-Years
14%
Alkermes Plc
NASDAQ:ALKS
Depreciation & Amortization
$30.3m
CAGR 3-Years
-27%
CAGR 5-Years
-18%
CAGR 10-Years
-10%
Prothena Corporation PLC
NASDAQ:PRTA
Depreciation & Amortization
$898k
CAGR 3-Years
9%
CAGR 5-Years
-11%
CAGR 10-Years
1%
M
Mural Oncology PLC
NASDAQ:MURA
Depreciation & Amortization
$3.5m
CAGR 3-Years
33%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Amarin Corporation PLC
Glance View

Market Cap
342.3m USD
Industry
Biotechnology

Amarin Corp. Plc is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. The firm is focused on the commercialization and development of therapeutics for cardiovascular disease management. The firm operates through the development and commercialization of Vascepa segment. Its lead product, Vascepa (icosapent ethyl) capsule for use as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The firm sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.

AMRN Intrinsic Value
22.15 USD
Undervaluation 26%
Intrinsic Value
Price

See Also

What is Amarin Corporation PLC's Depreciation & Amortization?
Depreciation & Amortization
3.1m USD

Based on the financial report for Sep 30, 2025, Amarin Corporation PLC's Depreciation & Amortization amounts to 3.1m USD.

What is Amarin Corporation PLC's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
14%

Over the last year, the Depreciation & Amortization growth was 2%. The average annual Depreciation & Amortization growth rates for Amarin Corporation PLC have been -1% over the past three years , 11% over the past five years , and 14% over the past ten years .

Back to Top